Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock

Novo Nordisk (NVO) shares have lost 25.1% in the past three months compared with the industry's decline of 17.7%. The company has also underperformed the sector and the S&P 500 during the same time frame, as seen in the chart below. The stock is currently trading below both its 50 and 200-day moving averages. NVO Stock Underperforms the Industry, Sector & the S&P 500 Zacks Investment ResearchImage Source: Zacks Investment Research Novo Nordisk's stock price primarily dipped due to disappointing third-quarte ...